The Role of Molecular Testing in Treatment Decisions for NSCLC

Opinion
Video

This video segment explores the critical role of biomarker testing in identifying patients with ALK-positive NSCLC, discussing the clinical characteristics that guide the use of ALK inhibitors and addressing challenges in implementing comprehensive molecular testing in community settings.

Video content above is prompted by the following:

  • What characteristics make this patient particularly suitable for treatment with an ALK inhibitor?
  • How important is biomarker testing in informing treatment decisions?
  • What is your approach to testing and what barriers are there for testing in the community?
Recent Videos
6 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
Related Content